$1.6 million gift from Morris-Singer Foundation established COVID-19 hotline and telemedicine services for primary care
On Mar. 24, 2020, the Andrew and Corey Morris-Singer Foundation donated $1.6 million to OHSU to support the…
The Simmons Cancer Center joined elite National Comprehensive Cancer Network
On Mar. 24, 2020, the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern announced it had joined…
Partner Therapeutics announced initiation of clinical trial to evaluate Leukine in patients with COVID-19
On Mar. 24, 2020, Partner Therapeutics that Leukine (sargramostim, rhu-GM-CSF) is being assessed in the SARPAC trial (sargramostim…
Novavax NanoFlu achieved all primary endpoints in phase 3 clinical trial
On Mar. 24, 2020, Novavax announced positive top-line results of its pivotal Phase 3 clinical trial of NanoFlu,…
City of Hope researchers developing COVID-19 vaccine
On Mar. 24, 2020, City of Hope announced that it had employed its vast expertise using the immune…
U of A research projects shared $58 million in federal funding
On Mar. 24, 2020, the University of Alberta (U of A) announced that a Public health study was…
3M partnered with Ford to help further accelerate COVID-19 response
On Mar. 24, 2020, 3M and Ford Motor announced a partnership to increase the production of 3M’s powered…
Agriculture | Biotechnology | Disease | Therapeutics | USDA | Veterinary
MatMaCorp’s DNA and RNA testing platform could help protect the U.S. pork supply from African swine fever
On Mar. 24, 2020, MatMaCorp announced the successful evaluation of a genetic test to detect African swine fever…
NIH online resources support COVID-19 workers training to protect their own health
On Mar. 23, 2020, the National Institutes of Health (NIH) announced that it had launched an important online…
Cumberland Pharma Announced Initiative To Expand Availability Of VIBATIV® To Treat Hospital-Acquired & Ventilator-Associated Pneumonia Resulting From Coronavirus Infections
On Mar. 23, 2020, Cumberland Pharmaceuticals announced a national initiative to support the treatment of patients with hospital-acquired…
Emory’s DRIVE, Ridgeback partnered for drug versus coronavirus
On Mar. 23, 2020, Drug Innovation Ventures at Emory (DRIVE), and Ridgeback Biotherapeutics announced a collaboration to rapidly…
serum therapy used as possible COVID-19 treatment
On Mar. 23, 2020, researchers at Washington University School of Medicine in St. Louis announced they were investigating…
Soligenix and University of Hawaii at Manoa initiate work on novel Coronavirus vaccine for COVID-19
On Mar. 23, 2020, Soligenix announced that its ongoing collaboration with the University of Hawaii at Manoa (UH…
CSL Group to help battle Coronavirus
On Mar. 23, 2020, CSL announced that it was exploring development of a hyperimmune serum that could be…
Mount Sinai developing an ‘end-to-end’ diagnostics solution for COVID-19
On Mar. 23, 2020, an expert team of researchers and clinicians in microbiology, virology, pathology, molecular science, and…
Amneal accelerated distribution and production of hydroxychloroquine sulfate to meet potential needs of COVID-19 patients
On Mar. 20, 2020, Amneal Pharma announced that it was responding to the national COVID-19 health emergency by…
University of Pennsylvania $1.5 billion Hospital Pavilion construction allowed to continue
On Mar. 20, 2020, the University of Pennsylvania announced that Pavilion project construction would be allowed to continue…
Adaptive Biotechnologies and Microsoft expanded partnership to decode COVID-19 immune response and provide open data access
On Mar. 20, 2020, Adaptive Biotechnologies and Microsoft announced they were leveraging their existing partnership mapping population-wide adaptive…
Novartis commited to donate up to 130 million doses of hydroxychloroquine to support the global COVID-19 pandemic response
On Mar. 20, 2020, Novartis announced its commitment to donate up to 130 million doses of generic hydroxychloroquine…
New study expanded understanding of influenza-associated complications
On Mar. 20, 2020, a study was published in JAMA that expands the understanding of influenza-associated complications. Influenza…
CDC | Disease | Therapeutics
The CDC reported the pace of tuberculosis decline in the U.S. slowed in recent years
On Mar. 20, 2020, the Centers for Disease Control and Prevention (CDC) reported that tuberculosis (TB) incidence in…
Cardax releases white paper on the potential role of Astaxanthin in treatment of Coronavirus disease
On Mar. 20, 2020, Cardax released a white paper outlining the potential role of astaxanthin in the treatment…
FDA granted Bellerophon emergency expanded access for INOpulse for treatment of COVID-19 virus
On Mar. 20, 2020, Bellerophon Therapeutics announced the U.S. Food and Drug Administration (FDA) had granted emergency expanded…
Mylan ramped up U.S. manufacturing of hydroxychloroquine sulfate tablets to meet potential COVID-19 patient needs
On Mar. 19, 2020, Mylan announced it had restarted production of hydroxychloroquine sulfate tablets at its West Virginia…
Roche initiated phase III clinical trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 pneumonia
On Mar. 19, 2020, Roche announced it was working with the U.S. Food & Drug Administration (FDA) to…
UArizona Cancer Center received $69M grant forsSkin cancer prevention study
On Mar. 19, 2020, The UArizona Cancer Center announced it was awarded a five-year, $6.9 million prestigious Program…
FDA approved Epclusa (Sofosbuvir/Velpatasvir) for children with Chronic Hepatitis C infection
On Mar. 19, 2020, Gilead Sciences announced the U.S. Food and Drug Administration (FDA) had approved a supplemental…
Cumberland Pharmaceuticals announced initiative to expand availability of Caldolor to treat fevers associated with Coronavirus Infections
On Apr. 1, 2020, Cumberland Pharma announced a national initiative to support hospitals and clinics that use Caldolor…
Teva donated potential COVID-19 treatment, hydroxychloroquine sulfate tablets to hospitals nationwide
On Mar. 19, 2020, Teva announced the immediate donation of more than 6 million doses of hydroxychloroquine sulfate…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Medical Device | Non-Profit Research | Therapeutics | Vaccine
Leading Stanford Alumni Scientists and Physicians Launch StartX Med COVID-19 Task Force
On Mar. 18, 2020, StartX, a non-profit startup community of more than 1500 Stanford faculty and alumni founders,…